These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24492671)

  • 1. Noncompetitive inhibition of proton-coupled folate transporter by myricetin.
    Furumiya M; Inoue K; Nishijima C; Yamashiro T; Inaoka E; Ohta K; Hayashi Y; Yuasa H
    Drug Metab Pharmacokinet; 2014; 29(4):312-6. PubMed ID: 24492671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained inhibition of proton-coupled folate transporter by myricetin.
    Furumiya M; Yamashiro T; Inoue K; Nishijima C; Ohta K; Hayashi Y; Yuasa H
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):154-9. PubMed ID: 25801697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic and time-dependent features of sustained inhibitory effect of myricetin on folate transport by proton-coupled folate transporter.
    Yamashiro T; Ohta K; Inoue K; Furumiya M; Hayashi Y; Yuasa H
    Drug Metab Pharmacokinet; 2015 Oct; 30(5):341-6. PubMed ID: 26403086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of epigallocatechin gallate on drug transport mediated by the proton-coupled folate transporter.
    Kissei M; Itoh T; Narawa T
    Drug Metab Pharmacokinet; 2014; 29(5):367-72. PubMed ID: 24695276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibitory effects of myricetin on human proton-coupled folate transporter: Comparison with its effects on rat proton-coupled folate transporter and human riboflavin transporter 3.
    Yamashiro T; Yasujima T; Ohta K; Inoue K; Yuasa H
    Drug Metab Pharmacokinet; 2017 Dec; 32(6):311-314. PubMed ID: 29162466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model.
    Inoue K; Nakai Y; Ueda S; Kamigaso S; Ohta KY; Hatakeyama M; Hayashi Y; Otagiri M; Yuasa H
    Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G660-8. PubMed ID: 18174275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Characterization of Reduced Folate Carrier and Protein-Coupled Folate Transporter for Antifolates Accumulation in Non-Small Cell Lung Cancer Cells.
    Wang Y; Luo J; Bai M; Ma Z; Xu Y; Liu D; Jiang H; Ma S; Zhang S
    Drug Metab Dispos; 2024 Oct; 52(11):1332-1344. PubMed ID: 39261014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective transport of amethopterin enantiomers by the proton-coupled folate transporter.
    Narawa T; Itoh T
    Drug Metab Pharmacokinet; 2010; 25(3):283-9. PubMed ID: 20610887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Extrapolation of the Effects of Dolutegravir and Other HIV Integrase Inhibitors on Folate Transport Pathways.
    Zamek-Gliszczynski MJ; Zhang X; Mudunuru J; Du Y; Chen JL; Taskar KS; Huang J; Huang Y; Romach EH
    Drug Metab Dispos; 2019 Aug; 47(8):890-898. PubMed ID: 31167838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Tyr residues that enhance folate substrate binding and constrain oscillation of the proton-coupled folate transporter (PCFT-SLC46A1).
    Visentin M; Unal ES; Najmi M; Fiser A; Zhao R; Goldman ID
    Am J Physiol Cell Physiol; 2015 Apr; 308(8):C631-41. PubMed ID: 25608532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction.
    Qiu A; Min SH; Jansen M; Malhotra U; Tsai E; Cabelof DC; Matherly LH; Zhao R; Akabas MH; Goldman ID
    Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1669-78. PubMed ID: 17898134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituted cysteine accessibility reveals a novel transmembrane 2-3 reentrant loop and functional role for transmembrane domain 2 in the human proton-coupled folate transporter.
    Wilson MR; Hou Z; Matherly LH
    J Biol Chem; 2014 Sep; 289(36):25287-95. PubMed ID: 25053408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the amino acid residue responsible for the myricetin sensitivity of human proton-coupled folate transporter.
    Yamashiro T; Yasujima T; Ohta K; Inoue K; Yuasa H
    Sci Rep; 2019 Dec; 9(1):18105. PubMed ID: 31792273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds.
    Lemos C; Peters GJ; Jansen G; Martel F; Calhau C
    Eur J Nutr; 2007 Sep; 46(6):329-36. PubMed ID: 17712586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and functional characteristics of proton-coupled folate transporter.
    Yuasa H; Inoue K; Hayashi Y
    J Pharm Sci; 2009 May; 98(5):1608-16. PubMed ID: 18823045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific contribution of proton-coupled folate transporter/haem carrier protein 1 in the intestinal absorption of methotrexate in rats.
    Yokooji T; Mori N; Murakami T
    J Pharm Pharmacol; 2009 Jul; 61(7):911-8. PubMed ID: 19589233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haem and folate transport by proton-coupled folate transporter/haem carrier protein 1 (SLC46A1).
    Laftah AH; Latunde-Dada GO; Fakih S; Hider RC; Simpson RJ; McKie AT
    Br J Nutr; 2009 Apr; 101(8):1150-6. PubMed ID: 18782461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the tryptophan residues in proton-coupled folate transporter (PCFT-SLC46A1) function.
    Najmi M; Zhao R; Fiser A; Goldman ID
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C150-7. PubMed ID: 27251438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular identity and characterization of a Proton-coupled Folate Transporter--PCFT; biological ramifications and impact on the activity of pemetrexed.
    Zhao R; Goldman ID
    Cancer Metastasis Rev; 2007 Mar; 26(1):129-39. PubMed ID: 17340171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.
    Matherly LH; Hou Z; Gangjee A
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):1-15. PubMed ID: 29127457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.